Defects and glassy dynamics in solid He-4: Perspectives and current status

We review the anomalous behavior of solid He-4 at low temperatures with particular attention to the role of structural defects present in solid. The discussion centers around the possible role of two level systems and structural glassy components for inducing the observed anomalies. We propose that the origin of glassy behavior is due to the dynamics of defects like dislocations formed in He-4. Within the developed framework of glassy components in a solid, we give a summary of the results and predictions for the effects that cover the mechanical, thermodynamic, viscoelastic, and electro-elastic contributions of the glassy response of solid He-4. Our proposed glass model for solid He-4 has several implications: (1) The anomalous properties of He-4 can be accounted for by allowing defects to freeze out at lowest temperatures. The dynamics of solid He-4 is governed by glasslike (glassy) relaxation processes and the distribution of relaxation times varies significantly between different torsional oscillator, shear modulus, and dielectric function experiments. (2) Any defect freeze-out will be accompanied by thermodynamic signatures consistent with entropy contributions from defects. It follows that such entropy contribution is much smaller than the required superfluid fraction, yet it is sufficient to account for excess entropy at lowest temperatures. (3) We predict a Cole-Cole type relation between the real and imaginary part of the response functions for rotational and planar shear that is occurring due to the dynamics of defects. Similar results apply for other response functions. (4) Using the framework of glassy dynamics, we predict low-frequency yet to be measured electro-elastic features in defect rich He-4 crystals. These predictions allow one to directly test the ideas and very presence of glassy contributions in He-4.Comment: 33 pages, 13 figure

Retargeting azithromycin analogues to have dual-modality antimalarial activity

Background: Resistance to front-line antimalarials (artemisinin combination therapies) is spreading, and development of new drug treatment strategies to rapidly kill Plasmodium spp. malaria parasites is urgently needed. Azithromycin is a clinically used macrolide antibiotic proposed as a partner drug for combination therapy in malaria, which has also been tested as monotherapy. However, its slow-killing 'delayed-death' activity against the parasite's apicoplast organelle and suboptimal activity as monotherapy limit its application as a potential malaria treatment. Here, we explore a panel of azithromycin analogues and demonstrate that chemical modifications can be used to greatly improve the speed and potency of antimalarial action. Results: Investigation of 84 azithromycin analogues revealed nanomolar quick-killing potency directed against the very earliest stage of parasite development within red blood cells. Indeed, the best analogue exhibited 1600-fold higher potency than azithromycin with less than 48 hrs treatment in vitro. Analogues were effective against zoonotic Plasmodium knowlesi malaria parasites and against both multi-drug and artemisinin-resistant Plasmodium falciparum lines. Metabolomic profiles of azithromycin analogue-treated parasites suggested activity in the parasite food vacuole and mitochondria were disrupted. Moreover, unlike the food vacuole-targeting drug chloroquine, azithromycin and analogues were active across blood-stage development, including merozoite invasion, suggesting that these macrolides have a multi-factorial mechanism of quick-killing activity. The positioning of functional groups added to azithromycin and its quick-killing analogues altered their activity against bacterial-like ribosomes but had minimal change on 'quick-killing' activity. Apicoplast minus parasites remained susceptible to both azithromycin and its analogues, further demonstrating that quick-killing is independent of apicoplast-targeting, delayed-death activity. Conclusion: We show that azithromycin and analogues can rapidly kill malaria parasite asexual blood stages via a fast action mechanism. Development of azithromycin and analogues as antimalarials offers the possibility of targeting parasites through both a quick-killing and delayed-death mechanism of action in a single, multifactorial chemotype.Amy L. Burns, Brad E. Sleebs, Ghizal Siddiqui, Amanda E. De Paoli, Dovile Anderson, Benjamin Liffner, Richard Harvey, James G. Beeson, Darren J. Creek, Christopher D. Goodman, Geoffrey I. McFadden, and Danny W. Wilso

Targeting malaria parasites with novel derivatives of azithromycin

Introduction: The spread of artemisinin resistant Plasmodium falciparum parasites is of global concern and highlights the need to identify new antimalarials for future treatments. Azithromycin, a macrolide antibiotic used clinically against malaria, kills parasites via two mechanisms: ‘delayed death’ by inhibiting the bacterium-like ribosomes of the apicoplast, and ‘quick-killing’ that kills rapidly across the entire blood stage development. Methods: Here, 22 azithromycin analogues were explored for delayed death and quick-killing activities against P. falciparum (the most virulent human malaria) and P. knowlesi (a monkey parasite that frequently infects humans). Results: Seventeen analogues showed improved quick-killing against both Plasmodium species, with up to 38 to 20-fold higher potency over azithromycin after less than 48 or 28 hours of treatment for P. falciparum and P. knowlesi, respectively. Quick-killing analogues maintained activity throughout the blood stage lifecycle, including ring stages of P. falciparum parasites (5-fold more selective against P. falciparum than human cells. Isopentenyl pyrophosphate supplemented parasites that lacked an apicoplast were equally sensitive to quick-killing analogues, confirming that the quick killing activity of these drugs was not directed at the apicoplast. Further, activity against the related apicoplast containing parasite Toxoplasma gondii and the gram-positive bacterium Streptococcus pneumoniae did not show improvement over azithromycin, highlighting the specific improvement in antimalarial quick-killing activity. Metabolomic profiling of parasites subjected to the most potent compound showed a build-up of non-haemoglobin derived peptides that was similar to chloroquine, while also exhibiting accumulation of haemoglobin-derived peptides that was absent for chloroquine treatment. Discussion: The azithromycin analogues characterised in this study expand the structural diversity over previously reported quick-killing compounds and provide new starting points to develop azithromycin analogues with quickkilling antimalarial activity.Amy L. Burns, Brad E. Sleebs, Maria Gancheva, Kimberley T. McLean, Ghizal Siddiqui, Henrietta Venter, James G. Beeson, Ryan O, Handley, Darren J. Creek, Shutao Ma, Sonja Frölich, Christopher D. Goodman, Geoffrey I. McFadden, and Danny W. Wilso

Mystify me: Coke, terror and the symbolic immortality boost

A panel on “Marketing as Mystification” convened at the 2011 Academy of Marketing conference in Liverpool. Ideas from the Liverpool event were supplemented by commentaries from selected other authors. Each commentary explores the aspects of “mystification” observable in marketing discourses and practices. In what follows, Laufer interprets marketing mystification as modern form of sophism, Dholakia and Firat discuss mystifying ways that inequality is marketed, Varman analyzes the perversion and mystification of “development” via neoliberal marketing of “social entrepreneurship,” Mikkonen explores mystifying marketing representations of gays and lesbians, and Freund and Jacobi present a fascinating interpretation of how Coca-Cola advertising mystically reassures us that our difficult, dangerous lifeworld is actually quite hunky-dory. </jats:p

Poliovirus seroprevalence before and after interruption of poliovirus transmission in Kano State, Nigeria.

INTRODUCTION: In September 2015, Nigeria was removed from the list of polio-endemic countries after more than 12months had passed since the detection of last wild poliovirus case in the country on 24 July 2014. We are presenting here a report of two polio seroprevalence surveys conducted in September 2013 and October 2014, respectively, in the Kano state of northern Nigeria. METHODS: Health facility based seroprevalence surveys were undertaken at Murtala Mohammad Specialist Hospital, Kano. Parents or guardians of children aged 6-9months, 36-47months, 5-9years and 10-14years in 2013 and 6-9months and 19-22months (corresponding to 6-9months range at the time of 2013 survey) in 2014 presenting to the outpatient department, were approached for participation, screened for eligibility and asked to provide informed consent. A questionnaire was administered and a blood sample collected for polio neutralization assay. RESULTS: Among subjects aged 6-9months in the 2013 survey, seroprevalence was 58% (95% confidence interval [CI] 51-66%) to poliovirus type 1, 42% (95% CI 34-50%) to poliovirus type 2, and 52% (95% CI 44-60%) to poliovirus type 3. Among children 36-47months and older, seroprevalence was 85% or higher for all three serotypes. In 2014, seroprevalence in 6-9month infants was 72% (95% CI 65-79%) for type 1, 59% (95% CI 52-66%) for type 2, and 65% (95% CI 57-72%) for type 3 and in 19-22months, 80% (95% CI 74-85%), 57% (49-63%) and 78% (71-83%) respectively. Seroprevalence was positively associated with history of increasing oral poliovirus vaccine doses. CONCLUSIONS: There was significant improvement in seroprevalence in 2014 over the 2013 levels indicating a positive impact of recent programmatic interventions. However the continued low seroprevalence in 6-9month age is a concern and calls for improved immunization efforts to sustain the polio-free Nigeria

The flyby anomaly: a multivariate analysis approach

[EN] The flyby anomaly is the unexpected variation of the asymptotic post-encounter velocity of a spacecraft with respect to the pre-encounter velocity as it performs a slingshot manoeuvre. This effect has been detected in, at least, six flybys of the Earth but it has not appeared in other recent flybys. In order to find a pattern in these, apparently contradictory, data several phenomenological formulas have been proposed but all have failed to predict a new result in agreement with the observations. In this paper we use a multivariate dimensional analysis approach to propose a fitting of the data in terms of the local parameters at perigee, as it would occur if this anomaly comes from an unknown fifth force with latitude dependence. Under this assumption, we estimate the range of this force around 300 km .Acedo Rodríguez, L. (2017). The flyby anomaly: a multivariate analysis approach. Astrophysics and Space Science. 362(2):1-7. doi:10.1007/s10509-017-3025-zS173622Acedo, L.: Adv. Space Res. 54, 788 (2014). 1505.06884Acedo, L.: Universe 1, 422 (2015a)Acedo, L.: Galaxies 3, 113 (2015b)Acedo, L.: Mon. Not. R. Astron. Soc. 463(2), 2119 (2016)Acedo, L., Bel, L.: Astron. Nachr. (2016). 1602.03669Adler, S.L.: Int. J. Mod. Phys. A 25, 4577 (2010). 0908.2414 . doi: 10.1142/S0217751X10050706Adler, S.L.: In: Proceedings of the Conference in Honour of Murray Gellimann’s 80th Birthday, p. 352 (2011). doi: 10.1142/9789814335614_0032Anderson, J.D., Laing, P.A., Lau, E.L., Liu, A.S., Nieto, M.M., Turyshev, S.G.: Phys. Rev. D 65(8), 082004 (2002). gr-qc/0104064 . doi: 10.1103/PhysRevD.65.082004Anderson, J.D., Campbell, J.K., Ekelund, J.E., Ellis, J., Jordan, J.F.: Phys. Rev. Lett. 100(9), 091102 (2008). doi: 10.1103/PhysRevLett.100.091102Atchison, J.A., Peck, M.A., Streetman, B.J.: J. Guid. Control Dyn. 33, 1115 (2010). doi: 10.2514/1.47413Border, J.S., Pham, T., Bedrossian, A., Chang, C.: 2015 Delta Differential One-way Ranging in Dsn Telecommunication Link Design Handbook (810-005). http://deepspace.jpl.nasa.gov/dsndocs/810-005/210/210A.pdf . Accessed: 2016-11-17Burns, J.A.: Am. J. Phys. 44(10), 944 (1976). doi: 10.1119/1.10237Busack, H.-J.: arXiv e-prints 1312.1139 (2013)Butrica, A.J.: In: From Engineering Science to Big Science: The NACA and NASA Collier Trophy Research Project Winners, p. 251 (1998)Cahill, R.T.: arXiv e-prints 0804.0039 (2008)Chamberlin, A., Yeomans, D., Giorgini, J., Chodas, P.: 2016 Horizons Ephemeris System. http://ssd.jpl.nasa.gov/horizons.cgi . Accessed: 2016-10-27Danby, J.M.A.: Fundamentals of Celestial Mechanics, 2nd edn. Willmann-Bell, Richmond (1988)Dickey, J.O., Bender, P.L., Faller, J.E., Newhall, X.X., Ricklefs, R.L., Ries, J.G., Shelus, P.J., Veillet, C., Whipple, A.L., Wiant, J.R., Williams, J.G., Yoder, C.F.: Science 265, 482 (1994). doi: 10.1126/science.265.5171.482Feng, J.L., Fornal, B., Galon, I., Gardner, S., Somolinsky, J., Tait, T.M.P., Tanedo, P.: Phys. Rev. Lett. 117, 071803 (2016). doi: 10.1103/PhysRevLett.117.071803Fischbach, E., Buncher, J.B., Gruenwald, J.T., Jenkins, J.H., Krause, D.E., Mattes, J.J., Newport, J.R.: Space Sci. Rev. 145, 285 (2009). doi: 10.1007/s11214-009-9518-5Folkner, W.M., Williamns, J.G., Boggs, D.H., Park, R.S., Kuchynka, P.: IPN Progress Report 42(196) (2014)Franklin, A., Fischback, E.: The Rise and Fall of the Fifth Force. Discovery, Pursuit, and Justification in Modern Physics, 2nd edn. Springer, New York (2016)Hackmann, E., Lämmerzahl, C.: In: 38th COSPAR Scientific Assembly. COSPAR Meeting, vol. 38, p. 3 (2010)Hafele, J.C.: arXiv e-prints 0904.0383 (2009)Iorio, L.: Sch. Res. Exch. 2009 807695 (2009). 0811.3924 . doi: 10.3814/2009/807695Iorio, L.: Astron. J. 142, 68 (2011a). 1102.4572 . doi: 10.1088/0004-6256/142/3/68Iorio, L.: Mon. Not. R. Astron. Soc. 415, 1266 (2011b). 1102.0212Iorio, L.: Galaxies 1, 192 (2013). 1306.3166Iorio, L.: Int. J. Mod. Phys. D 24, 1530015 (2015). 1412.7673Jouannic, B., Noomen, R., van den IJSel, J.A.A.: In: Proceedings of the 25th International Symposium on Space Flight Dynamics ISSFD, Munich (Germany), 2015Krasinsky, G.A., Brumberg, V.A.: Celest. Mech. Dyn. Astron. 90, 267 (2004)Lämmerzahl, C., Preuss, O., Dittus, H.: In: Dittus, H., Lämmerzahl, C., Turyshev, S.G. (eds.) Lasers, Clocks and Drag-Free Control: Exploration of Relativistic Gravity in Space. Astrophysics and Space Science Library, vol. 349, p. 75 (2008). doi: 10.1007/978-3-540-34377-6_3McCulloch, M.E.: Mon. Not. R. Astron. Soc. 389, 57 (2008). 0806.4159 . doi: 10.1111/j.1745-3933.2008.00523.xPinheiro, M.J.: Phys. Lett. A 378, 3007 (2014). 1404.1101Pinheiro, M.J.: Mon. Not. R. Astron. Soc. 461(4), 3948 (2016)Rievers, B., Lämmerzahl, C.: Ann. Phys. 523, 439 (2011). 1104.3985 . doi: 10.1002/andp.201100081Thompson, P.F., Abrahamson, M., Ardalan, S., Bordi, J.: In: 24th AAS/AIAA Space Flight Mechanics Meeting, Santa Fe, New Mexico, January 26–30, 2014, 2014. http://hdl.handle.net/2014/45519Turyshev, S.G., Toth, V.T.: Living Rev. Relativ. 13, 4 (2010). 1001.3686 . doi: 10.12942/lrr-2010-4Turyshev, S.G., Toth, V.T., Kinsella, G., Lee, S.-C., Lok, S.M., Ellis, J.: Phys. Rev. Lett. 108(24), 241101 (2012). 1204.2507 . doi: 10.1103/PhysRevLett.108.241101Vallado, D.A.: Fundamentals of Astrodynamics and Applications, 2nd edn. (2004)Williams, J.G., Turyshev, S.G., Boggs, D.H.: Phys. Rev. Lett. 93(26), 261101 (2004). gr-qc/0411113 . doi: 10.1103/PhysRevLett.93.26110

Transduction of intracellular and intercellular dynamics in yeast glycolytic oscillations.

AbstractUnder certain well-defined conditions, a population of yeast cells exhibits glycolytic oscillations that synchronize through intercellular acetaldehyde. This implies that the dynamic phenomenon of the oscillation propagates within and between cells. We here develop a method to establish by which route dynamics propagate through a biological reaction network. Application of the method to yeast demonstrates how the oscillations and the synchronization signal can be transduced. That transduction is not so much through the backbone of glycolysis, as via the Gibbs energy and redox coenzyme couples (ATP/ADP, and NADH/NAD), and via both intra- and intercellular acetaldehyde

Customer emotions in service failure and recovery encounters

Emotions play a significant role in the workplace, and considerable attention has been given to the study of employee emotions. Customers also play a central function in organizations, but much less is known about customer emotions. This chapter reviews the growing literature on customer emotions in employee–customer interfaces with a focus on service failure and recovery encounters, where emotions are heightened. It highlights emerging themes and key findings, addresses the measurement, modeling, and management of customer emotions, and identifies future research streams. Attention is given to emotional contagion, relationships between affective and cognitive processes, customer anger, customer rage, and individual differences